Michael Morris is a member of the Scientific Advisory Board of Molecular Partners, which he joined in 2025. He is the Steven A. Greenberg Chair in Prostate Cancer Research, and Section Head of Prostate Cancer of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center (MSKCC), Scientific Chair of the Prostate Cancer Clinical Trials Consortium Scientific Committee and Co-Chair of the Genitourinary Committee of the National Cancer Institute’s Alliance for Clinical Trials in Oncology. Michael earned his medical degree from the Mount Sinai School of Medicine in New York and performed his internship and residency in Internal Medicine at Columbia Presbyterian Medical Center. He then completed his medical oncology fellowship at MSKCC.